Eterna Therapeutics
ERNA
#10942
Rank
โ‚น0.36 B
Marketcap
โ‚น312.88
Share price
-5.48%
Change (1 day)
129.88%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -โ‚น1,41,299

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น1,56,130. In 2022 the company made an earnings per share (EPS) of -โ‚น3,00,121 an increase over its 2021 EPS that were of -โ‚น19,82,800.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น1,41,299
2022-โ‚น3,00,121-84.86%
2021-โ‚น19,82,800

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น244.17-100.16%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น203.18-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚น104.93-100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.49-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น130.68-100.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น67.73-100.04%๐Ÿ‡บ๐Ÿ‡ธ USA